Management of psoriatic lesions associated with anti-TNF therapy in patients with IBD

被引：3
|
作者：
Denadai, Rafael [1 ]
Teixeira, Fabio V. [1 ]
Saad-Hossnethe, Rogerio [1 ]
机构：
[1] Univ State Sao Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, BR-17516707 Sao Paulo, Brazil
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2012年 / 9卷 / 12期
关键词：
INFLAMMATORY-BOWEL-DISEASE; NECROSIS FACTOR THERAPY; INFLIXIMAB; ONSET;
D O I：
10.1038/nrgastro.2012.125-c1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：744 / 744
页数：1
相关论文
共 50 条
  • [1] Predictive biomarkers for anti-TNF alpha therapy in IBD patients
    Kumar, Manoj
    Murugesan, Selvasankar
    Ibrahim, Nazira
    Elawad, Mamoun
    Al Khodor, Souhaila
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [2] Predictive biomarkers for anti-TNF alpha therapy in IBD patients
    Manoj Kumar
    Selvasankar Murugesan
    Nazira Ibrahim
    Mamoun Elawad
    Souhaila Al Khodor
    Journal of Translational Medicine, 22
  • [3] IBD Antibodies to anti-TNF therapy-consequences for IBD management
    van Deen, Welmoed K.
    Hommes, Daniel W.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (08) : 446 - 448
  • [4] Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety
    de Lima, A.
    Zelinkova, Z.
    van der Ent, C.
    Steegers, E. A. P.
    van der Woude, C. J.
    GUT, 2016, 65 (08) : 1261 - 1268
  • [5] Is There an Increased Risk of Lymphoma and Malignancies Under Anti-TNF Therapy in IBD?
    Lakatos, P. L.
    Miheller, P.
    CURRENT DRUG TARGETS, 2010, 11 (02) : 179 - 186
  • [6] Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD
    Yoon, Soon Man
    Haritunians, Talin
    Chhina, Sultan
    Liu, Zhenqiu
    Yang, Shaohong
    Landers, Carol
    Li, Dalin
    Ye, Byong Duk
    Shih, David
    Vasiliauskas, Eric A.
    Ippoliti, Andrew
    Rabizadeh, Shervin
    Targan, Stephan R.
    Melmed, Gil Y.
    McGovern, Dermot P. B.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (08) : 382 - 393
  • [7] Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy
    Schierova, Dagmar
    Roubalova, Radka
    Kolar, Martin
    Stehlikova, Zuzana
    Rob, Filip
    Jackova, Zuzana
    Coufal, Stepan
    Thon, Tomas
    Mihula, Martin
    Modrak, Martin
    Kverka, Miloslav
    Bajer, Lukas
    Kostovcikova, Klara
    Drastich, Pavel
    Hercogova, Jana
    Novakova, Michaela
    Vasatko, Martin
    Lukas, Milan
    Tlaskalova-Hogenova, Helena
    Zakostelska, Zuzana Jiraskova
    CELLS, 2021, 10 (11)
  • [8] Anti-TNF therapy for paediatric IBD: the Scottish national experience
    Cameron, F. L.
    Wilson, M. L.
    Basheer, N.
    Jamison, A.
    McGrogan, P.
    Bisset, W. M.
    Gillett, P. M.
    Russell, R. K.
    Wilson, D. C.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2015, 100 (04) : 399 - 405
  • [9] Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study
    Guerra, Ivan
    Perez-Jeldres, Tamara
    Iborra, Marisa
    Algaba, Alicia
    Monfort, David
    Calvet, Xavier
    Chaparro, Maria
    Manosa, Miriam
    Hinojosa, Esther
    Minguez, Miguel
    Ortiz de Zarate, Jone
    Marquez, Lucia
    Prieto, Vanessa
    Garcia-Sanchez, Valle
    Guardiola, Jordi
    Esther Rodriguez, G.
    Dolores Martin-Arranz, Maria
    Garcia-Tercero, Ivan
    Sicilia, Beatriz
    Masedo, Angeles
    Lorente, Rufo
    Rivero, Montserrat
    Fernandez-Salazar, Luis
    Gutierrez, Ana
    Van Domselaar, Manuel
    Lopez-SanRoman, Antonio
    Ber, Yolanda
    Garcia-Sepulcre, Marife
    Ramos, Laura
    Bermejo, Fernando
    Gisbert, Javier P.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (04) : 894 - 901
  • [10] Anti-TNF associated psoriasis
    Hamlin, P. J.
    Goodfield, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (02) : 308 - 309
12345